Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum

Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum

US Patent 12098207 · Granted Sep 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of anti-IL-36R antibodies for treatment of generalized pustular psoriasis2025
Use of anti-IL-36R antibodies for treatment of generalized pustular psoriasis2025
Methods of treating inflammatory diseases2025
Anti-IL-23 antibodies2021
Pharmaceutical formulation comprising ciclesonide2021
Muscarinic antagonists and combinations thereof for the treatment of airway dise2020
Biomarkers useful in the treatment of IL-23A related diseases2019
Ciclesonide for the treatment of airway disease in horses2019
Muscarinic antagonists and combinations thereof for the treatment of airway dise2019
Ciclesonide for the treatment of airway disease in horses2019
Ciclesonide for the treatment of airway disease in horses2018
Muscarinic antagonists and combinations thereof for the treatment of airway dise2016